You're experiencing any kind of infection
Many peptides are not approved by regulators, and their safety, purity, and interactions are not well established
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease, counteracts NSAID-induced intestinal damage
BPC-157 is most associated in animal studies with new blood vessel formation and tissue protection at the injury site
Research in rats, for instance, shows that BPC-157 can protect against QTc prolongation in the heart, a condition that can lead to serious and even fatal arrhythmias
The tragedy of cases like that fuel a lot of the frustration doctors have with complementary medicine